Transcriptional activation of gammaherpesviral oncogene promoters by the hepatitis B viral X protein (HBx)

DNA and Cell Biology

Volumn 23, Issue 3, 2004, Pages 141-148

  Assogba, Barnabe Dossou ^a   Paik, Nak Whan ^a   Rho, Hyune M O ^a  

^a Inje University   (South Korea)

Author keywords

[No Author keywords available]

Indexed keywords

HEPATITIS B VIRAL X PROTEIN; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; UNCLASSIFIED DRUG; VIRUS PROTEIN;

ADENOVIRUS 5; ARTICLE; CONTROLLED STUDY; DNA VIRUS; HEPATITIS B VIRUS; HERPES VIRUS; HUMAN; HUMAN CELL; LEUKEMIA CELL LINE; LYMPHOMA; MUTATION; NONHUMAN; NUCLEOTIDE SEQUENCE; ONCOGENE; PRIORITY JOURNAL; PROMOTER REGION; SITE DIRECTED MUTAGENESIS; T CELL LEUKEMIA; TRANSCRIPTION INITIATION; VIRAL GENETICS; VIRUS INFECTION; VIRUS STRAIN; WART VIRUS;

GAMMAHERPESVIRINAE; HUMANS; JURKAT CELLS; NF-KAPPA B; ONCOGENE PROTEINS, VIRAL; PROMOTER REGIONS (GENETICS); RNA, MESSENGER; TRANS-ACTIVATION (GENETICS); TRANS-ACTIVATORS;

ADENOVIRIDAE; DNA VIRUSES; HEPATITIS B VIRUS; HERPESVIRIDAE; HUMAN ADENOVIRUS TYPE 5; HUMAN HERPESVIRUS 4; HUMAN PAPILLOMAVIRUS; HUMAN PAPILLOMAVIRUS TYPE 16; HUMAN PAPILLOMAVIRUS TYPES; PAPILLOMAVIRUS; SAIMIRI; SAIMIRIINE HERPESVIRUS 2;

EID: 1642407888     PISSN: 10445498     EISSN: None     Source Type: Journal    
DOI: 10.1089/104454904322964733     Document Type: Article

References (45)

1. ASSOGBA, B.D., CHOI, B.H., and RHO, H.M. (2002). Transcriptional activation of the promoter of human cytomegalovirus immediate early gene (CMV-IE) by the hepatitis B viral X protein (HBx) through the NF-kappaB site. Virus Res. 84, 171-179.
2. BIESINGER, B., MULLER-FLECKENSTEIN, I., SIMMER, B., LANG, G., WITTMANN, S., PLATZER, E., DESROSIERS, R.C., and FLECKENSTEIN, B. (1992). Stable growth transformation of human T lymphocytes by herpesvirus saimiri. Proc. Natl. Acad. Sci. USA 89, 3116-3119.
3. BIESINGER, B., TRIMBLE, J.J., DESROSIERS, R.C., and FLECKENSTEIN, B. (1990). The divergence between two oncogenic Herpesvirus saimiri strains in a genomic region related to the transforming phenotype. Virology 176, 505-514.
4. BRESSLER, P., BROWN, K., TIMMER, W., BOURS, V., SIEBENLIST, U., and FAUCI, A.S. (1993). Mutational analysis of the p50 subunit of NF-kappa B and inhibition of NF-kappa B activity by trans-dominant p50 mutants. J. Virol. 67, 288-293.
5. BRINK, A.A., VERVOORT, M.B., MIDDELDORP, J.M., MEIJER, C.J., and VAN DEN BRULE, A.J. (1998). Nucleic acid sequence-based amplification, a new method for analysis of spliced and unspliced Epstein-Barr virus latent transcripts, and its comparison with reverse transcriptase PCR. J. Clin. Microbiol. 36, 3164-3169.
6. CHIEN, M.L., and HAMMARSKJOLD, M.L. (2000). Epstein-Barr virus latent membrane protein (LMP1) induces specific NF-kappaB complexes in human T-lymphoid cells. Virus Res. 67, 17-30.
7. CHOI, C.Y., CHOI, B.H., PARK, G.T., and RHO, H.M. (1997). Activating transcription factor 2 (ATF2) down-regulates hepatitis B virus X promoter activity by the competition for the activating protein 1 binding site and the formation of the ATF2-Jun heterodimer. J. Biol. Chem. 272, 16934-16939.
8. CHOI, C.Y., PARK, G.T., and RHO, H.M. (1996). A positive regulatory sequence of hepatitis B viral small X promoter. Eur. J. Biochem. 239, 579-587.
9. CHOMCZYNSKI, P., and SACCHI, N. (1987). Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. Anal. Biochem. 162, 156-159.
10. COHEN, J.I., WANG, F., MANNICK, J., and KIEFF, E. (1989). Epstein-Barr virus nuclear protein 2 is a key determinant of lymphocyte transformation. Proc. Natl Acad. Sci. USA 86, 9558-9562.
11. DAMANIA, B., CHOI, J.K., and JUNG, J.U. (2000). Signaling activities of gammaherpesvirus membrane proteins. J. Virol. 74, 1593-1601.
12. DAVIDOVICI, B., KARAKIS, I., BOURBOULIA, D., ARIAD, S., ZONG, J., BENHARROCH, D., DUPIN, N., WEISS, R., HAYWARD, G., SAROV, B., et al. (2001). Seroepidemiology and molecular epidemiology of Kaposi's sarcoma-associated herpesvirus among Jewish population groups in Israel. J. Natl. Cancer Inst. 93, 194-202.
13. DEVERGNE, O., CAHIR MCFARLAND, E.D., MOSIALOS, G., IZUMI, K.M., WARE, C.F., and KIEFF, E. (1998). Role of the TRAF binding site and NF-κB activation in Epstein-Barr virus latent membrane protein 1-induced cell gene expression. J. Virol. 72, 7900-7908.
14. DUBOISE, S.M., GUO, J., CZAJAK, S., DESROSIERS, R.C., and JUNG, J.U. (1998), Mutation of the Lck-binding motif of Tip enhances lymphoid cell activation by herpesvirus saimiri. J. Virol. 72, 1308-1313.
15. GEORGOPOULOS, N.T., PROFFITT, J.L., and BLAIR, G.E. (2000). Transcriptional regulation of the major histocompatibility complex (MHC) class I heavy chain, TAP1 and LMP2 genes by the human papillomavirus (HPV) type 6b, 16 and 18 E7 oncoproteins. Oncogene 19, 4930-4935.
16. GOMEZ-GONZALO, M., CARRETERO, M., RULLAS, J., LARAPEZZI, E., ARAMBURU, J., BERKHOUT, B., ALCAMI, J., and LOPEZ-CABRERA, M. (2001). The hepatitis B virus X protein induces HIV-1 replication and transcription in synergy with T-cell activation signals: Functional roles of NF-kappaB/NF-AT and SP1-binding sites in the HIV-1 long terminal repeat promoter. J. Biol. Chem. 276, 35435-35443.
17. GRASSMANN, R., and FLECKENSTEIN, B. (1989). Selectable recombinant herpesvirus saimiri is capable of persisting in a human T-cell line. J. Virol. 63, 1818-1821.
18. GRIFFIN, B.E. (2000). Epstein-Barr virus (EBV) and human disease: Facts, opinions and problems. Mutat. Res. 462, 395-405.
19. HARADA, S., and YANAGI, K. (1991). Amino acid sequence homology of Epstein-Barr virus nuclear antigen-2 to adenovirus E1A, human papilloma virus-16 E7 and SV40 large T antigen in the functional domains for growth transformation. Oncogene 6, 461-462.
20. HILLER, C., TAMGUNEY, G., STOLTE, N., MATZ-RENSING, K., LORENZEN, D., HOR, S., THURAU, M., WITTMANN, S., SLAVIN, S., and FLICKENSCHER, H. (2000). Herpesvirus saimiri pathogenicity enhanced by thymidine kinase of herpes simplex virus. Virology 278, 445-455.
21. IZUMI, K.M., and KIEFF, E.D. (1997). The Epstein-Barr virus oncogene product latent membrane protein 1 engages the tumor necrosis factor receptor-associated death domain protein to mediate B lymphocyte growth transformation and activate NF-κB. Proc. Natl. Acad. Sci. USA 94, 12592-12597.
22. IZUMI, K.M., KAYE, K.M., and KIEFF, E.D. (1997). The Epstein-Barr virus LMPl amino acid sequence that engages tumor necrosis factor receptor associated factors is critical for primary B lymphocyte growth transformation. Proc. Natl. Acad. Sci. USA 94, 1447-1452.
23. KAYE, K.M., IZUMI, K.M., and KIEFF, E. (1993). Epstein-Barr virus latent membrane protein 1 is essential for B-lymphocyte growth transformation. Proc. Natl. Acad. Sci. USA 90, 9150-9154.
24. LAURE, F., ZAGURY, D., SAIMOT, A.G., GALLO, R.C., HAHN, B.H., and BRECHOT, C. (1985). Hepatitis B virus DNA sequences in lymphoid cells from patients with AIDS and AIDS-related complex. Science 229, 561-563.
25. LEE, D.H., CHOI, B.H., and RHO, H.M. (1999). The synergistic transactivation of the hepatitis B viral (HBV) pregenomic promoter by the E6 protein of human papillomavirus type 16 (HPV-16 E6) with HBV X protein was mediated through the API site of E element in the enhancer I (EnI) in human liver cell. Biochem. Biophys. Res. Commun. 265, 62-66.
26. LUND, T., MEDVECZKY, M.M., and MEDVECZKY, P.G. (1997). Herpesvirus saimiri Tip-484 membrane protein markedly increases p561ck activity in T cells. J. Virol. 71, 378-382.
27. MAYAMA, S., CUEVAS, L.E., SHELDON, J., OMAR, O.H., SMITH, D.H., OKONG, P., et al. (1998). Prevalence and transmission of Kaposi's sarcoma-associated herpesvirus (human herpesvirus 8) in Ugandan children and adolescents. Int. J. Cancer 11, 817-820.
28. NIEDOBITEK, G., and YOUNG, L.S. (1994). Epstein-Barr virus persistence and virus-associated tumours. Lancet 343, 333-335.
29. PATHMANATHAN, R., PRASAD, U., SADLER, R., FLYNN, K., RAAB-TRAUB, N. (1995). Clonal proliferations of cells infected with Epstein-Barr virus in preinvasive lesions related to nasopharyngeal carcinoma. N. Engl. J. Med. 333, 693-698.
30. PATI, S., CAVROIS, M., GUO, H.G., FOULKE, J.S., Jr., KIM, J., FELDMAN, R.A., and REITZ, M. (2001). Activation of NF-kappaB by the human herpesvirus 8 chemokine receptor ORF74: Evidence for a paracrine model of Kaposi's sarcoma pathogenesis. J. Virol. 75, 8660-8673.
31. RAHMAN, A., ANWAR, K.N., TRUE, A.L., and MALIK, A.B. (1999). Thrombin-induced p65 homodimer binding to downstream NF-kappa B site of the promoter mediates endothelial ICAM-1 expression and neutrophil adhesion. J. Immunol. 162, 5466-5476.
32. SAMANIEGO, F., PATI, S., KARP, J., PRAKASH, O., and BOSE, D. (2001). Human herpesvirus 8 K1-associated nuclear factor-kappa B-dependent promoter activity: Role in Kaposi's sarcoma inflammation? J. Natl. Cancer Inst. Monogr. 28, 15-23.
33. SCHWARZ, M., and MURPHY, P.M. (2001). Kaposi's sarcoma-associated herpesvirus G protein-coupled receptor constitutively activates NF-kappa B and induces proinflammatory cytokine and chemokine production via a C-terminal signaling determinant. J. Immunol. 167, 505-513.
34. SJOBLOM-HALLEN, A., YANG, W., JANSSON, A., and RYMO, L. (1999). Silencing of the Epstein-Barr virus latent membrane protein 1 gene by the Max-Madl-mSin3A modulator of chromatin structure. J. Virol. 73, 2983-2993.
35. SMITH, C.S., SHEARER, W.T. (1994). Activation of NF-kappa B and immunoglobulin expression in response to platelet activating factor in a human B cell line. Cell Immunol. 155, 292-303.
36. SOULIER, J., GROLLET, L., OKSENHENDLER, E., CACOUB, P., CAZALS-HATEM, D., BABINET, P., D'AGAY, M.F., CLAUVEL, J.P., RAPHAEL, M., DEGOS, L., et al. (1995). Kaposi's sarcoma-associated herpesvirus-like DNA sequences in multicentric Castleman's disease. Blood 86, 1276-1280.
37. SU, F., and SCHNEIDER, R.J. (1996). Hepatitis B virus HBx protein activates transcription factor NF-kappaB by acting on multiple cytoplasmic inhibitors of rel-related proteins. J. Virol. 70, 4558-4566.
38. SUBRAMANIAN, T., TARODI, B., and CHINNADURAI, G. (1995). Functional similarity between adenovirus E1B 19-kDa protein and proteins encoded by Bcl-2 proto-oncogene and Epstein-Barr virus BHRF1 gene. Curr. Top. Microbiol. Immunol. 199, 153-161.
39. TAIEB, A., POMPOUGNAC, E., HANS, P., FONTAN, I., and MALEVILLE, J. (1985). Pediatric papular acrodermatitis and double primary infection by the hepatitis B virus and the Epstein-Barr virus. Ann. Dermatol. Venereol. 112, 889-892.
40. TRIVEDI, P., SPINSANTI, P., CUOMO, L., VOLPE, M., TAKADA, K., FRATI, L., and FAGGIONI, A. (2001). Differential regulation of Epstein-Barr virus (EBV) latent gene expression in Burkitt's lymphoma cells infected with a recombinant EBV strain. J. Virol. 75, 4929-4935.
41. TSAI, C.N., LEE, C.M., CHIEN, C.K., KUO, S.C., and CHANG, Y.S. (1999). Additive effect of Sp1 and Sp3 in regulation of the ED-LIE promoter of the EBV LMP 1 gene in human epithelial cells. Virology 261, 288-294.
42. WANG, D., LIEBOWITZ, D., and KIEFF, E. (1985). An EBV membrane protein expressed in immortalized lymphocytes transforms established rodent cells. Cell 43, 831-840.
43. WANG, D., LIEBOWITZ, D., WANG, F., GREGORY, C., RICKINSON, A., LARSON, R., SPRINGER, T., and KIEFF, E. (1988). Epstein-Barr virus latent infection membrane protein alters the human B-lymphocyte phenotype: Deletion of the amino terminus abolishes activity. J. Virol. 62, 4173-4184.
44. YATES, J., WARREN, N., and SUGDEN, B. (1985). Stable replication of plasmids derived from Epstein-Barr virus in various mammalian cells. Nature 313, 812-815.
45. ZELDIS, J.B., MUGISHIMA, H., STEINBERG, H.N., NIR, E., and GALE, R.P. (1986). In vitro hepatitis B virus infection of human bone marrow cells. J. Clin. Invest. 78, 411-417.